Related Experiment Video
Updated: Jul 26, 2026

09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
The omnipotent platelet. Part II: Further observations
1Chestnut Hill Medical Center, MA 02167, USA.
Medical Hypotheses
|July 1, 1997
Summary
Platelet counts change during acute conditions, initially decreasing then increasing. Elevated platelet counts after injury, without X-ray evidence, suggest further investigation with a bone scan is needed.
Area of Science:
- Hematology
- Medical Diagnostics
- Pathophysiology
Background:
- Platelet count dynamics are crucial for understanding acute injury and disease progression.
- Initial thrombocytopenia followed by thrombocytosis is a characteristic platelet response pattern.
Purpose of the Study:
- To elucidate the significance of platelet count fluctuations in diagnosing and monitoring acute conditions.
- To establish diagnostic indicators for further investigation based on platelet response.
Main Methods:
- Observational analysis of platelet count changes (thrombocytopenia and thrombocytosis) in patients with acute injury or pathology.
- Correlation of platelet response patterns with diagnostic imaging (X-ray) and further tests (bone scan).
Main Results:
- Observed a biphasic platelet response: initial decrease (thrombocytopenia) followed by an increase (thrombocytosis).
- Identified that negative X-ray findings coupled with significant thrombocytosis warrant a bone scan for further evaluation.
- Platelet response serves as an indicator of injury or pathology progression, similar to sedimentation rate.
Conclusions:
- Platelet count monitoring is a valuable tool in assessing acute medical conditions.
- The pattern of thrombocytopenia followed by thrombocytosis, especially with negative X-rays, is a key diagnostic clue.
- Bone scans are indicated in specific cases of thrombocytosis to further investigate underlying pathology.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

